Physician profile
Ryan Basak
NPI 1750867784
$594.29
in general payments reported to CMS, 2019-2025
10 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $63.98 · 2022: $34.01 · 2023: $87.62 · 2024: $287 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $255.12 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $121.82 | 2025 | Rexulti |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.04 | 2024 | Lifevest |
| Xeris Pharmaceuticals, INC. | $20.32 | 2023 | Gvoke Hypopen |
| Gilead Sciences, INC. | $19.91 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $17.64 | 2021 | |
| Amgen INC. | $16.75 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.90 | 2021 | |
| Merck Sharp & Dohme LLC | $14.10 | 2022 | |
| Medtronic, INC. | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Basak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.